A larger overlapping 10-Mb inversion61 involving MSH2 exons 1–7 explained 60% of affected individuals in a cohort of suspected cryptic Lynch syndrome,62 and consequently that inversion is now being captured by MLPA testing (Note S1). The gene discussed is MSH2; the disease is Lynch syndrome.